iCell® Cardiomyocytes Kit, 11713

Cardiomyocytes derived from human iPS cells, frozen

More Views

From: 595 USD

Options

* Required Fields

Catalog # (Select a product)
Cardiomyocytes derived from human iPS cells, frozen
From: 595 USD

Overview

Cardiovascular disease encompasses a wide range of clinical conditions that are a consequence of genetics, physiologic and metabolic conditions as well as adverse drug reactions. The availability of human cell models that could represent and be used to interrogate these various factors would have a profound impact on the effort to find new medicines and cures.

iCell® Cardiomyocytes are human heart cells that recapitulate apparently healthy human cardiac biology and overcome the limitations of existing heart cell models, offering these benefits:
• 95% pure population of ventricular, atrial, and nodal cells
• Clinically relevant cardiac disease phenotypes
• Relevant clinical targets for cardiovascular disease
• Highly reproducible across a wide range of applications
With the most peer-reviewed publications and application notes/protocols, as well as the lowest cost per cell of any commercially available iPS cell-derived cardiomyocyte product, iCell® Cardiomyocytes enable a wide range of applications spanning disease research, drug discovery, toxicity testing, and regenerative medicine, including:

• Cardiac hypertrophy studies: Novel human in vitro model used to recapitulate clinical phenotypes, detect known and novel biomarkers, and identify new targets for drug discovery and therapy.
• Arrhythmia testing: Highly predictive model used for detecting drug-induced arrhythmia – resulting in changing regulatory paradigms
• Cardiotoxicity assessment: Retrospective analyses leveraged to uncover previously undetected mechanisms of drug-induced cardiotoxicity and provide relevant data in support of Investigational New Drug (IND) applications.
• Cardiac cell therapy: Compatibility with bioengineered, implantable scaffolds used to stimulate heart repair following myocardial infarction.

Certain products are only available in select territories. Please contact Product & Scientific Support at techsupport@stemcell.com for further information.
Components:
iCell® Cardiomyocytes Kit, 11713, 1 x 10^6 cells (Catalog #R1105)
          iCell® Cardiomyocytes, 11713, 1 x 10^6 cells
          iCell® Cardiomyocytes Plating Medium, 30 mL
          iCell® Cardiomyocytes Maintenance Medium, 100 mL
 
iCell® Cardiomyocytes Kit, 11713, 4 x 10^6 cells (Catalog #R1106)
          iCell® Cardiomyocytes, 11713, 4 x 10^6 cells
          iCell® Cardiomyocytes Plating Medium, 30 mL
          iCell® Cardiomyocytes Maintenance Medium, 2 x 100 mL
 
iCell® Cardiomyocytes Kit 3 pack, 11713, 3 vials x 1 x 10^6 cells (Catalog #R1117)
          iCell® Cardiomyocytes, 11713, 3 vials x 1 x 10^6 cells
          iCell® Cardiomyocytes Plating Medium, 30 mL
          iCell® Cardiomyocytes Maintenance Medium, 100 mL
Subtype:
Frozen
Cell Type:
Cardiac Cells, PSC-Derived
Species:
Human
Cell and Tissue Source:
Pluripotent Stem Cells
Brand:
iCell
Donor Status:
Normal

Scientific Resources

Educational Materials

(7)

Product Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

STEMCELL TECHNOLOGIES INC.’S QUALITY MANAGEMENT SYSTEM IS CERTIFIED TO ISO 13485. PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.